Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer

Purpose: Lung cancer remains the leading cause of cancer-related deaths worldwide and novel therapeutic approaches targeting crucial pathways are urgently needed to improve its treatment. Differentiation-based therapeutics (Methylxanthines) and phosphodiesterase inhibitors (type 4 and 5), have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Domvri, Kalliopi, Zarogoulidis, Konstantinos, Zogas, Nikolaos, Zarogoulidis, Paul, Petanidis, Savvas, Porpodis, Konstantinos, Kioseoglou, Efrosini, Hohenforst-Schmidt, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688917/
https://www.ncbi.nlm.nih.gov/pubmed/29151951
http://dx.doi.org/10.7150/jca.21783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688917/
https://www.ncbi.nlm.nih.gov/pubmed/29151951
http://dx.doi.org/10.7150/jca.21783

Ejemplares similares